{"id":1553,"date":"2024-12-03T20:38:30","date_gmt":"2024-12-03T12:38:30","guid":{"rendered":"https:\/\/p15.projs.ifdemo.com\/viva\/?page_id=1553"},"modified":"2026-05-20T18:04:03","modified_gmt":"2026-05-20T10:04:03","slug":"scientists-doctors","status":"publish","type":"page","link":"https:\/\/p15.projs.ifdemo.com\/viva\/about-viva\/our-galaxy\/scientists-doctors\/","title":{"rendered":"Scientists & Doctors"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n \t
\n\t\t

Scientists & Doctors<\/h1> \n\t\t
<\/i><\/a><\/i><\/span>About VIVA<\/a><\/i><\/span>Our Galaxy<\/a><\/i><\/span>Scientists & Doctors<\/div> \n\t<\/div>\n\t
<\/div>\n\t\"Bottom\n<\/div>\n\n\n \t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Scientists & Doctors<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

At VIVA, we believe that scientists and doctors are the driving force behind cures and hope for children with cancer.
<\/span>Our mission to save lives is made possible through their dedication, expertise, and relentless pursuit of discovery.
<\/span>These individuals are the key intermediaries between our vision and our ultimate beneficiaries \u2013 the children and families affected by cancer.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Professor Dario Campana<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Professor, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore<\/span><\/i>
<\/span>Mrs Lee Kong Chian Chair in Advanced Cellular Therapy<\/span><\/i><\/p>

Professor Dario Campana obtained his MD from the University of Torino and his PhD from the University of Milano, Italy. Before joining St. Jude Children\u2019s Research Hospital in Memphis, he was a Lecturer in Immunology at the Royal Free Hospital, University of London (UK). At St. Jude, he served as Vice Chair for Laboratory Research in the Department of Oncology and Professor of Paediatrics at the University of Tennessee.<\/span><\/p>

Currently based at NUS, Professor Campana\u2019s research focuses on cancer immunotherapy, including immune-cell engineering and minimal residual disease detection in leukaemia. He has published over 300 papers and holds multiple patents advancing cellular therapy worldwide.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Professor Allen Yeoh<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

VIVA\u2013Goh Foundation Professor in Paediatric Oncology, Yong Loo Lin School of Medicine, NUS<\/span><\/i>
<\/span>Head and Senior Consultant, Division of Paediatric Haematology and Oncology, National University Hospital<\/span><\/i><\/p>

Professor Allen Yeoh is the principal investigator of the Malaysia\u2013Singapore ALL and AML trials, achieving projected cure rates exceeding 80% and 60%, respectively. His work focuses on childhood leukaemia, risk-stratification biomarkers, and precision therapy.<\/span><\/p>

He leads the VIVA\u2013NUS Centre for Translational Research in Acute Leukaemia (CenTRAL), integrating genomics and MRD technologies to guide clinical management. Together with Professor Campana, he co-leads the CAR-T Cell Programme at NUHS.<\/span><\/p>

Professor Yeoh was the first Singaporean to receive the American Society of Hematology Merit Award and has been honoured with the Singapore Youth Award, Asian Innovation Award (Gold), and the National Outstanding Clinician Scientist Award.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Adj Assoc Prof David Low<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Deputy Chief Executive Officer (Clinical), National Neuroscience Institute (NNI), Singapore<\/span><\/i>
<\/span> Senior Consultant, Department of Neurosurgery, NNI<\/span><\/i>
<\/span> Clinical Associate Professor, Duke\u2013NUS Medical School<\/span><\/i><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Adj Clinical Prof David Low is a neurosurgeon specialising in paediatric neurosurgery, neuro-oncology (brain tumour surgery), epilepsy surgery and hydrocephalus.<\/span><\/p>

He obtained his MBBCh from the Royal College of Surgeons in Ireland (2000), MRCS (Edinburgh), MMed (Surgery, NUS), and FRCS (Edinburgh). He completed a Ministry of Health HMDP fellowship in Paediatric Neurosurgery at The Hospital for Sick Children, Toronto (2011).<\/span><\/p>

He previously served as Head of Neurosurgery at KK Women\u2019s and Children\u2019s Hospital and Program Director for the SingHealth Neurosurgical Residency Programme (2013\u20132019). He later became Head of Department, Neurosurgery at NNI@TTSH (2019\u20132023) before assuming his current role as Deputy CEO (Clinical) at NNI.<\/span><\/p>

Prof Low continues to train future neurosurgeons and lead clinical and academic programmes within the SingHealth\u2013Duke-NUS Neuroscience Academic Clinical Programme.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Amos Loh<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Senior Consultant, Department of Paediatric Surgery\u00a0
<\/em>Deputy Chair, Division of Surgery,\u00a0KK\u00a0Women\u2019s\u00a0and Children\u2019s Hospital\u00a0Singapore\u202f\u00a0<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Amos Loh obtained his medical degree from the National University of Singapore in 2002 and went on to train in general surgery and then paediatric surgery and was awarded the College of Surgeons Gold Medal in paediatric surgery in 2011. He trained as a fellow in paediatric surgical oncology at St Jude Children\u2019s Research Hospital and was awarded a National Medical Research Council research training award for his research fellowship in the lab of Michael Dyer, PhD.<\/span><\/p>

He is presently Deputy Chair of the Division of Surgery and a Senior Consultant with the Department of Paediatric Surgery, KK\u00a0Women\u2019s\u00a0and\u00a0Children\u2019s Hospital (KKH), with a clinical practice and academic research focus in paediatric surgical oncology. Dr Loh\u2019s areas of interest are clinical and translational research in paediatric solid tumours.\u00a0In particular, his\u00a0lab focuses on the development of models of paediatric solid tumours for preclinical development of novel therapeutics, and the discovery of biomarkers for prognostication and therapeutic stratification of paediatric solid tumours.<\/span><\/p>

He chairs the VIVA-KKH Paediatric Brain and Solid Tumour Programme, a multi-institution collaboration that brings together clinicians and scientists to cooperate on advancing the care and research of paediatric brain and solid tumours in Singapore.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Soh Shui Yen<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Head & Senior Consultant Haematology\/Oncology Service<\/span><\/i>
<\/span>Paediatric Brain and Solid Tumour Programme, KK\u00a0Women’s\u00a0and Children’s Hospital Singapore<\/span><\/i>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Soh Shui-Yen is the Head and Senior Consultant from the Paediatric Haematology\/Oncology Service of KK Women\u2019s and Children\u2019s Hospital (KKH) in Singapore. Dr Soh graduated from the Faculty of Medicine, National University of Singapore (NUS). She received her Paediatric Medicine training in Singapore and also completed 1 year of Paediatric Oncology clinical fellowship at the Hospital of Sick Children in Toronto, Canada.<\/span><\/p>

Her academic interests are in paediatric brain and solid tumours, as well as in cellular and immunotherapies in cancer. She is currently the Chair of the Paediatric Oncology Group Singapore and a steering committee member of the VIVA-KKH Paediatric Brain and Solid Tumour Programme.<\/span><\/p>

She also holds teaching appointments with the NUS Yong Loo Lin School of Medicine, the Duke-NUS Graduate School of Medicine, the National\u00a0Technological University (NTU) \u2013 Lee Kong Chian (LKC) School of Medicine and the\u00a0SingHealth\u00a0Paediatrics Residency Programme.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Shawn Lee Hsien Ren<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Consultant, Division of Paediatric Haematology and Oncology, National University Hospital<\/span><\/span>\u00a0<\/span>
<\/span>Adjunct Assistant Professor, Department of Paediatrics, Yong Loo Lin School of Medicine, NUS<\/span><\/span>\u00a0<\/span><\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Shawn Lee graduated with MBBS from Yong Loo Lin School of Medicine, NUS in 2011 where he was awarded the Wong Poi Kwong Medal for Clinical Medicine. He went on to obtain his Master of Medicine (Paeds) and MRCPCH (UK) in 2015. In 2017, he was awarded the Exxon-Mobil Fellowship for Clinicians and also received the MOH Healthcare Scholarship for his Master of Clinical Investigation (MCI) which he obtained in 2019.<\/span><\/p>

He was\u00a0subsequently\u00a0awarded the NMRC Research Training Fellowship in 2019 where he embarked on a 3-year fellowship in\u00a0leukemia\u00a0genomics under Dr Yang Jun in St Jude Children\u2019s Hospital in Memphis, USA. In 2021, he was awarded the American Association for Cancer Research (AACR) Scholar-In-Training Award and Society of Hematologic Oncology Young Investigator Award for his work on genomic diversity of childhood\u00a0leukemia.\u00a0<\/span>\u00a0<\/span><\/p>

His research interests include individualised therapy in oncology, specifically pharmacogenomics to allow for tailoring of treatment therapy,\u00a0and also\u00a0immunogenomics to aid in prognostication, risk stratification and\u00a0optimal\u00a0utilisation of CAR-T and other immunotherapeutic agents.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Anthony Liu<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Honorary Clinical Assistant Professor, Department of Paediatrics & Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong<\/span><\/i>\u00a0
<\/span>Staff Oncologist,\u00a0Pediatric\u00a0Brain Tumour Program, The Hospital for Sick Children, Toronto, Canada\u00a0<\/span><\/i>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Anthony Liu joined the staff at The Hospital for Sick Children (SickKids) in 2024. Dr Liu obtained his Medical Degree with Honours from the University of\u00a0Hong Kong, and\u00a0completed his Paediatric and Paediatric Haematology\/Oncology training in Queen Mary Hospital, Hong Kong. Subsequently, he pursued a Clinical and Research Fellowship in Paediatric Neuro-Oncology at St. Jude Children\u2019s Research Hospital, spearheading landmark studies on circulating tumour DNA analysis for medulloblastoma and molecular profiling in rare CNS embryonal tumours.\u00a0<\/span>\u00a0<\/span><\/p>

Before his transition to Toronto, Dr Liu served as attending Paediatric Haematologist\/Oncologist at Hong Kong Children\u2019s Hospital, dedicating effort in parallel for capacity building in Paediatric Neuro-Oncology with providers from Asia.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Adj Assoc Prof Kenneth Chang<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Head, Department of Pathology and Laboratory Medicine, KK\u00a0Women\u2019s\u00a0and Children\u2019s Hospital\u00a0<\/span><\/i>\u00a0
<\/span>Adjunct Associate Professor, Duke\u2013NUS Medical School<\/span><\/i>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Adjunct Associate Professor Kenneth Chang is Deputy\u00a0Chairman\u00a0of the Division of Clinical Support Services and Senior Consultant Pathologist and Head of Molecular Pathology at the Department of Pathology and Laboratory Medicine at KK Women\u2019s and Children\u2019s Hospital in Singapore. He is Clinical Associate Professor at Duke-NUS Medical School, and Academic Vice-Chair for Clinical Service Transformation in the\u00a0SingHealth\u00a0Duke-NUS Pathology Academic Clinical Programme.\u00a0<\/span>\u00a0<\/span><\/p>

Within the SingHealth cluster, he is Director of the SingHealth Tissue Repository and Advanced Molecular Pathology Laboratory. He is the programme lead of the St Jude-KKH Asia-Pacific Paediatric Pathology Programme, a regional paediatric pathology programme supported by St Jude Children\u2019s Research Hospital, focused on capacity building for paediatric oncological pathology amongst a network of children\u2019s hospitals in Asia.<\/span><\/p>

He is also Visiting Professor at the Shanghai Children\u2019s Medical Centre\/Jiao Tong University, in Shanghai, People\u2019s Republic of China. Kenneth is an editorial board member of\u00a0Pediatric\u00a0and Developmental Pathology.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Michaela Seng<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Senior Consultant, Children\u2019s Blood and Cancer Centre, Department of Paediatric Haematology and Oncology, KK\u00a0<\/span>Women\u2019s<\/span>\u00a0and Children\u2019s Hospital<\/span><\/span>\u00a0<\/span>
<\/span>Duke-NUS Medical School<\/span><\/span>\u00a0<\/span><\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Michaela Seng is a Paediatric haematologist and oncologist in KK Women\u2019s and Children\u2019s Hospital who holds full specialist accreditation in both Australia and Singapore. She currently serves as the BMTCT Clinical Facility medical director and research lead in the KK Women’s and Children’s Blood and Cancer Centre.<\/span><\/p>

Her research interest is in the translation of innovative cell therapies for relapsed refractory cancers, motivated by the treatment failures and toxicities seen in her practice. In this regard, she runs several investigator-initiated cell therapy trials for adult and paediatric patients as the\u00a0Principle\u00a0Investigator.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Frances Yeap<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Consultant, Division of Paediatric Haematology and Oncology, Department of Paediatrics<\/span><\/i>
<\/span>Khoo Teck Puat – National University Children’s Medical Institute, National University Hospital<\/span><\/i><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Frances Yeap graduated from St Bartholomew\u2019s and The Royal London School of Medicine and Dentistry and returned to Singapore to complete her training in Paediatrics. Her clinical practice at the National University Hospital encompasses General Paediatrics and all aspects of Paediatric Haematology and Oncology.<\/span><\/p>

She has a special interest and expertise in Bone Marrow Transplant, particularly in transplants for non-malignant conditions and immunodeficiencies. Alongside her clinical work, Dr Yeap is actively involved in research focused on the genomics and molecular pathogenesis of childhood leukaemia, contributing to the development of precision medicine approaches for patients in Singapore and the region.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
Dr Sally Blair<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Independent Contractor, St Jude Global Alliance Asia Pacific Regional Program\u00a0
<\/em>Project Consultant, Division of Paediatric Oncology, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore\u00a0\u00a0
<\/em>Global Co-Ordinator, Vietnam\u00a0Pediatric\u00a0Hematology\u00a0Oncology Program\u00a0<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Dr Sally Blair holds an MBBS and MPH from the University of Sydney. She trained at The Children\u2019s Hospital at\u00a0Westmead, Australia, before moving to Singapore in 2007. Since then, she has been actively involved in regional and international paediatric oncology initiatives, including the St. Jude\u2013VIVA Forum in Paediatric Oncology.<\/span>\u00a0<\/span><\/p>

In her role with St. Jude Global, she focuses on building capacity and improving care standards for children with cancer and blood diseases across the Asia Pacific region.<\/span>\u00a0<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
More VIVA-Associated Scientists & Clinicians<\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Learn more about the doctors and researchers from the VIVA\u2013KKH Paediatric Brain and Solid Tumour Programme at <\/span>www.kkh.com.sg<\/span><\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tRead More<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Scientists & Doctors About VIVAOur GalaxyScientists & Doctors Scientists & Doctors At VIVA, we believe that scientists and doctors are the driving force behind cures and hope for children with cancer.Our mission to save lives is made possible through their dedication, expertise, and relentless pursuit of discovery.These individuals are the key intermediaries between our vision […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":1056,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-1553","page","type-page","status-publish","hentry"],"meta_box":[],"_links":{"self":[{"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/pages\/1553","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/comments?post=1553"}],"version-history":[{"count":76,"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/pages\/1553\/revisions"}],"predecessor-version":[{"id":13212,"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/pages\/1553\/revisions\/13212"}],"up":[{"embeddable":true,"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/pages\/1056"}],"wp:attachment":[{"href":"https:\/\/p15.projs.ifdemo.com\/viva\/wp-json\/wp\/v2\/media?parent=1553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}